Sign in
4

Changes in Ownership

Dogwood Therapeutics, Inc. Filed Acc 0001415889-22-005567

CHIEF EXECUTIVE OFFICER bought 7,500 shares at $4.52 ($33,900)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Duncan Gregory Scott CHIEF EXECUTIVE OFFICER 2022-05-23 Purchase +7,500 $4.52 $33,900 32,461 D
Open-market purchases · 7,500 sh · avg $4.52 · $33,900
Loading xslF345X03/form4-05242022_070548.xml…